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Hybridomas secreting monoclonal antibodies against an apparent strain-specific
cell surface antigen of Neisseria gonorrhoeae were produced. Spleen cells from
BALB/c mice immunized with whole gonococci were fused with mouse myeloma
cell line Sp2/0, and hybrid ceLls were selected in culture. One hybridoma that
secreted antibodies reactive with the immunizing strain was cloned by limiting
dilution to obtain cell lines secreting monoclonal antibodies. These antibodies
reacted with purified outer membranes from the immunizing strain as well as
with whole gonococci. Binding of antibodies to whole gonococci was highly strain
specific, with most gonococcal strains showing less than 1% of the binding with
the immunizing strain. Antibodies did not bind to the other Neisseria species
tested. Binding of monoclonal antibodies to whole gonococci of the immunizing
strain was not dependent on state of piliation. The extent of antibody binding did
vary in different colonial variants of the immunizing strain. Antibody bound to
cells from colonies that were transparent or of intermnediate opacity, but did not
bind to cells from deeply opaque colony variants.
The bacterial cell surface expresses a varied
array of surface components that can play an
important role in interactions with the host.
They can elicit host immune responses that
usually confer protection against subsequent in-
fection with the same organism (20). The ability
of Neisseria gonorrhoeae to cause infection may
involve the expression of surface antigens that
interact with the host. Some of these antigens
show antigenic variability among different gon-
ococcal strains. These antigens include pili (3),
principal outer membrane protein (8), and lipo-
polysaccharide (LPS)-derived polysaccharide
antigens (1). There are also proteins of the outer
membrane, termed colony opacity-associated
proteins, that may or may not be present on the
surface of a particular gonococcal strain (7). The
presence of these proteins has been correlated
with differences in opacity characteristics ofgon-
ococcal colonies and with differences in viru-
lence of the organism (14, 25).
Until now, studies on gonococcal surface an-
tigens have used antisera produced in animals
and have been subject to the difficulties inherent
in the use of such antisera. These problems
include the difficulty in preparing highly purified
antigens for immunization and in producing spe-
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cific antibodies against the antigens of interest.
To produce specific antibodies, antisera must
often be absorbed with crude mixtures of anti-
gens to remove unwanted cross-reacting anti-
bodies. This usually results in the production of
small, unstandardized batches of antibody that
are not very specific and are of low antibody
titer. The use of monoclonal antibodies, initially
developed by Kohler and Milstein (11), has al-
leviated many of these problems.
To study the antigenic mosaic of N. gonor-
rhoeae, we have applied hybridoma technology
to the production of highly specific monoclonal
antibodies that react with a surface antigen(s)
present on a single strain of N. gonorrhoeae and
have used these antibodies to study variability
of this antigen within that strain of the gonococ-
cus.
MATERLALS AND METHODS
Strains. N. gonorrhoeae strains FA1090 (used to
immunize mice), FA1035, FA1099, FA1048, D1574,
ATCC 19424, D1610, D1593, FA1083, FA1100, FA1039,
FA1086, and FA1092. N. flavescens, N. sicca ATCC
9913, N. perflava ATCC 14799, and Branhamella
catarrhalis ATCC 25238 were donated by P. Frederick
Sparling, University of North Carolina School of Med-
icine. Strain FA1090 is a serum-resistant, prototrophic
strain isolated from a patient with a probable dissem-
inated gonococcal infection. N. gonorrhoeae F62 was
donated by T. M. Buchanan, University of Washing-
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ton, Seattle. N. gonorrhoeae 116, 117, and 147 and N.
meningitidis serogroups A and B were laboratory
reference strains donated by G. Chandler, Laboratory
Improvement Program, Laboratory Section, Raleigh,
N.C. Haemophilus influenzae type b was donated by
John K. Read, University of North Carolina School of
Public Health.
Media and growth conditions. Gonococci were
grown on chocolate agar containing GC agar base
(BBL Microbiology Systems, Cockeysville, Md.), 1%
hemoglobin (BBL), and 1% IsoVitaleX (BBL) pre-
pared according to the manufacture's instructions.
Gonococci were also grown on GCB agar containing
GC base (Difco Laboratories, Detroit, Mich.) with
Kellogg's defined supplements (10). Gonococci were
grown at 370C for 16 to 18 h with a 5% CO2 atmosphere.
All strains were stored as stock cultures at -70°C in
Trypticase soy broth (BBL) containing 15% glycerol.
Gonococci were recovered from stocks for each exper-
iment to ensure minimal changes in antigenic and
morphological characteristics caused by repeated pas-
sage on laboratory media (2). For cell binding studies,
bacteria were grown on chocolate agar and were not
selected for a particular colony type, unless otherwise
specified.
Isolation of colony variants. Opacity variants
and piliated colony variants of N. gonorrhoeae were
identified on GCB agar, using the criteria of Swanson
(24).
Production of hybridomas. Somatic cell hybri-
domas secreting specific monoclonal antibodies were
produced with minor modification of the methods of
Oi and Herzenberg (17).
Normal culture media consisted ofRPMI 1640 (MA
Bioproducts, Walkersville, Md.) supplemented with
15% serum (fetal or newborn calf; GIBCO Laborato-
ries, Grand Island, N.Y.), 1 mM glutamine (GIBCO),
1 mM sodium pyruvate (MA Bioproducts), 50 U of
penicillin per ml, 50 ,ug of streptomycin per ml, 0.125
ug of amphotericin B per ml (MA Bioproducts), and
50 jig of gentamicin per ml (Garamycin; Schering
Corp., Kenilworth, N.J.). After fusion, hybrid cells
were selected in HAT medium (15) consisting of nor-
mal medium plus hypoxanthine (13.6 ug/ml; Sigma
Chemical Co., St. Louis, Mo.), aminopterin (0.176 ,Lg/
ml; Sigma), and thymidine (3.88 ,ug/ml; Sigma).
BALB/c mice of either sex, 10 to 12 weeks old, were
immunized with whole gonococci. N. gonorrhoeae
strain FA1090 was grown on chocolate agar for 16 to
18 h, and bacteria were suspended in Davis broth
(Difco) at approximately 2 x 107 colony-forming units/
ml. Mice were injected with 0.5 ml of fresh gonococcal
suspension intraperitoneally and boosted 15 days later
with an identical injection. Three days later, mice were
sacrificed. Approximately 108 spleen cells from im-
munized mice were fused with 5 x 107 Sp2/0 myeloma
cells (22), using 50% polyethylene glycol 1500 (BDH,
Poole, England), exactly as described by Oi and Her-
zenberg (17).
Detection of antibodies directed against the
gonococcus. Hybridoma antibodies were assayed for
their ability to bind to the cell surface of whole gono-
cocci by modification of the radioimmunoassay (RIA)
described by Stocker and Heusser (23). Flat-bottom
disposable polyvinyl microtiter plates (no. 1-220-29;
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Dynatech Laboratories, Inc., Alexandria, Va.) were
used. Gonococci or other bacteria were grown over-
night and harvested in phosphate-buffered saline
(PBS; Dulbecco; GIBCO). Bacteria were suspended in
PBS to give an optical density at 750 nm of 0.6. This
density of cells gave optimal binding of bacteria to
wells. Fifty microliters of bacterial suspension was
dispensed into each well and centrifuged at 1,500 x g
for 5 min at 4°C. With the plates at 4°C, each well
was gently filled with PBS containing 0.25% glutaral-
dehyde (Fisher Scientific Co., Pittsburgh, Pa.; 25%
aqueous). After 5 min at 4°C, PBS-glutaraldehyde was
aspirated off. This step and subsequent steps were all
done at room temperature. Wells were washed three
times with PBS to remove glutaraldehyde and then
were filled with PBS containing 1% newborn calf se-
rum, 1% bovine serum albumin, and 0.2% sodium azide
(RIA buffer). Plates were sealed with plastic incubated
at room temperature for 2 h and then stored at 4°C
until use. Plates retained stability for at least 1 month.
Initial hybridoma antibody screening was per-
formed by using '"I-labeled rabbit anti-mouse immu-
noglobulin G (IgG) to detect binding of mouse immu-
noglobulins to whole gonococci. Antibody to mouse
IgG was prepared in New Zealand white rabbits. Rab-
bits were subcutaneously injected in four sites with a
total of 100 pg of mouse IgG (Litton Bionetics, Ken-
sington, Md.) emulsified in Freund complete adjuvant.
Four weeks later, rabbits were injected subcutaneously
with a total of 100 pAg of mouse IgG emulsified in
Freund complete adjuvant. Rabbits were bled 4 weeks
later. Purified rabbit IgG fraction was prepared by
ammonium sulfate fractionation (9) and diethylamino-
ethyl-Sephacel (Pharmacia Fine Chemicals, Inc., Pis-
cataway, N.J.) ion-exchange chromatography in 0.01
M sodium phosphate buffer, pH 7.8. Crude rabbit IgG,
prepared by ammonium sulfate fractionation and
equilibrated with the same buffer by dialysis, was
passed throughout the column, and protein fractions
were collected. Protein fractions were pooled and con-
centrated on a B-15 Amicon concentrator (Amicon
Corp., Lexington, Mass.). Concentrated rabbit IgG was
tested by immunoelectrophoresis (Universal electro-
phoresis agarose film, Palo Alto, Calif.) using goat
anti-whole serum (Miles Laboratories, Inc., Elkhart,
Ind.) and goat anti-rabbit IgG (Miles) to check purity
of the material. Only IgG was detected by this method.
Purified rabbit anti-mouse IgG (1 mg/ml in PBS) was
labeled with carrier-free '2iodine (New England Nu-
clear Corp., Boston, Mass.) by the chloramine-T
method (16). One milligam of IgG was iodinated with
100 ,uCi of 125iodine. After labeling, iodinated IgG was
separated from free label by Sephadex G-25 (Phar-
macia) chromatography, equilibrated with PBS, pH
7.0. The specific activity of lnI-labeled rabbit anti-
mouse IgG was approximately 2 x l04 cpm per pg of
IgG.
Fifty microliters of undiluted culture supernatant
from master cultures was added to each well coated
with whole gonococci and incubated for 60 min at
37°C. Assays were performed in triplicate. After in-
cubation, wells were gently washed with RIA buffer
three times. Twenty-five microliters of '2I-labeled rab-
bit anti-mouse IgG containing 5 x 104 cpm was added
to each well and incubated for 60 min at 37°C. Wells
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were washed three times with RIA buffer. Individual
wells were cut from the plate and counted in a gamma
counter (Tri-Carb; Packard Instruments Co., Inc.,
Rockville, Md.). Control wells contained normal cul-
ture media. A test was considered positive if the mean
counts bound in wells with culture supernatants was
greater than three standard deviations above back-
ground binding. Wells with positive binding usually
exhibited greater than 1,000 cpm of "nI-labeled rabbit
anti-mouse IgG bound above background. Positive
hybridomas were cloned by limiting dilution, and
clones producing specific antibody were expanded in
culture.
Protein A binding assay. Protein A (Pharmacia)
was labeled with "niodine by the chloramine-T method
(16). One milligram of protein A was labeled with 1
mCi of "2'iodine and purified by Sephadex G-25 chro-
matography. The specific activity of labeled protein A
was approximately 6.3 x 105 cpm per ,ug of protein A.
Ascites fluid (diluted 1:50), serum (1:50), or culture
fluids (undiluted) containing monoclonal antibodies
were tested for binding to bacteria by the microplate
RIA as described above, with the modification that
wells were washed with PBS-1% bovine serum albu-
min-0.2% sodium azide (PBS-BSA). Fifty microliters
of '25I-labeled protein A( 5 x 104 cpm) was added to
each well and incubated for 60 min at 37°C. Wells
were washed with PBS-BSA and counted. Pooled
normal BALB/C mouse serum diluted 1:50 was used
as a control for nonspecific binding of radiolabeled
protein A.
Binding of antibodies to outer membranes and
LPS. Purified outer membranes from strain FA1090
were prepared according to Guymon et al. (6). This
method has been shown to yield outer membranes free
of detectable cytoplasmic constituents (6). Purified
LPS was prepared by the method of Perry et al. (18).
A RIA was used to detect antibody binding to either
purified outer membranes or LPS. Each microtiter
well was coated with 10 ,ug of outer membrane proteins
or purified LPS, using the coating buffers of Walls and
Palmer (26). To detect antibody binding, the '25I-la-
beled protein A binding assay as described above was
used. Hybridoma antibodies from ascites or serum
were tested at a 1:100 dilution, and culture fluids were
tested undiluted. Assays were performed in duplicate.
Antibody production. Monoclonal antibodies
were produced by injecting at least 2 x 106 viable
hybrid cells into BALB/c mice intraperitoneally to
induce ascites tumors or subcutaneously into the ab-
domen of mice to inluce solid subcutaneous tumors.
Monoclonal antibodies were harvested from ascites or
serum after 2 to 3 weeks and stored at -70°C.
Serum and ascites fluid were screened by agar elec-
trophoresis to detect monoclonal (paraprotein) im-
munoglobulins (Fig. 1). Agar electrophoresis was per-
formed on glass plates (8 by 14 cm), using 15 ml of
Noble agar (Difco) in 0.065 M sodium barbital buffer,
pH 8.6. Holes of 1 mm were punched, and 5-,l samples
were applied. Samples were electrophoresed for 1 h at
250 V, and gels were stained for protein with 0.25%
Coomassie brilliant blue in 9% acetic acid-45% meth-
anol for 1 h and destained in 7.5% acetic acid. The
bulges (arrows) in the electrophoretic pattern were
due to the presence of homogeneous (monoclonal) IgG
molecules migrating toward the cathode. Normal
mouse serum exhibited diffuse staining since it lacked
such homogeneous molecules.
Heavy-chain isotype analysis. Antibodies were
analyzed by immunoelectrophoresis (Universal film
agarose, Palo Alto, Calif.), using subclass-specific an-
tisera against mouse IgG of the classes IgGl, IgG2a,
IgG2b, and IgG3 (Litton Bionetics).
SDS-PAGE. Sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) was per-
formed as previously described (4), using the buffers
of Laemmli (12) or Shapiro et al. (21). Crude outer
membranes were prepared for electrophoresis by Sar-
kosyl (Geigy Chemicals) lysis. Cells were suspended in
0.5% Sarkosyl-5 mM ethylenediaminetetraacetic acid
in 0.1 M sodium phosphate buffer, pH 7.2, and incu-
bated at 37°C for 15 min. MgCl2 was added to a
concentration of 10 mM, deoxyribonuclease and ribo-
nuclease A were added to a concentration of 10 ug/ml,
and the cells were incubated for 15 min at 37°C.
Membranes were collected by centrifugation at 48,000
NMS
FIG. 1. Agar electrophoresis pattern of serum or ascites fluid exhibiting monoclonal (paraprotein) immu-
noglobulins. Arrows point to cathodal-migrating monoclonal components. NMS, Normal pooled BALB/c
mouse serum.
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x g for 20 min and suspended in distilled water.
RESULTS
BALB/c immune spleen cells, primed with
whole gonococci of strain FA1090, were fused
with Sp2/0 myeloma cells; fused cells were
seeded into master culture plates (106 cells/well).
Fifty-three of 96 wells (60%) showed growth of
hybrid cells after selection in HAT medium.
Culture supernatants from these 53 hybrids were
tested by RIA for binding to FA1090 gonococci.
Of 53 cultures tested, only 6 (11%) bound to the
immunizing strain. One hybridoma was cloned
by limiting dilution, and clones were tested for
specific antibody production. Fifteen clones se-
creted specific anti-FA1090 antibodies. Large
quantities of antibodies were produced in vivo
in BALB/c mice. Injection of 2 x 106 viable
hybrid cells was sufficient to induce either as-
INFECT. IMMUN.
cites or solid tumors. Over 80% of mice injected
grew tumors and secreted monoclonal antibody.
Strain specificity of antibodies. Mono-
clonal antibodies from eight clones of hybrido-
mas secreting anti-FA1090 antibodies were
tested for binding to the homologous immuniz-
ing strain, FA1090, and to other strains of gon-
ococci (16 strains), using the protein A solid-
phase binding assay. All monoclonal antibodies
reacted strongly with the homologous immuniz-
ing strain, FA1090 (10,000 to 20,000 cpm above
background), but showed little cross-reactivity
with other gonococci tested (Fig. 2; eight strains
shown). Although antibodies were tested at a
low dilution of 1:50, antibody titers were usually
1:5,000 to 1:10,000 in this assay. Each antibody
exhibited the same pattern ofreactivity, whether
tested at dilutions lower than or greater than 1:
















FIG. 2. Binding ofmonoclonal anti-FA1090 antibodies to different strains ofN. gonorrhoeae using a whole-
cell-binding 'I-labeled protein A RIA. All assays were performed in triplicate. Variation among triplicate
assays was less than 109o.
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rhoeae strain F62. Each of the eight antibodies
bound to strain F62, with less than 8% of the
counts bound to the homologous strain, FA1090.
Antibody from clone 1090-10.1 also cross-reacted
with strain FA1099, with less than 12% of the
counts bound to the homologous strain. Mono-
clonal antibodies exhibited less than 1% of ho-
mologous strain binding to other gonococcal
strains tested. Strains of gonococci tested in-
cluded AHU- and prototrophic auxotypes (5),
serum-resistant and serum-sensitive strains, and
strains isolated from disseminated gonococcal
infections and uncomplicated infections. SDS-
PAGE of outer membrane of these showed that
they had some differences in membrane protein
profiles, including differences in apparent molec-
ular weights of protein 1 of the outer membrane
(data not shown).
Antibodies were also tested for binding to
other Neisseria, including N. meningitidis se-
rogroups A and B, N. sicca ATCC 9913, N.
perflava ATCC'14799, N. flavescens, B. catar-
rhalis ATCC 25238, and H. influenzae type b.
No significant binding of antibodies to these
strains was observed compared with control val-
ues using normal mouse serum (data not shown).
Monoclonal antibody 1090-10.1 was tested for
binding to purified outer membranes from strain
FA1090 by RIA. The antibody bound to antigen
from the homologous strain even at a dilution of
10-5, but not with outer membranes from two
heterologous strains (Fig. 3). This antibody
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FIG. 3. Binding of monoclonal antibody 1090-10.1
to purified outer membranes from strain FA1090
(0), FA19 (A), and FA1035 (E). Binding was meas-
ured by the '25I-labeledprotein A RMA. Each dilution
was tested in duplicate with less than 10% variation
between samples.
FA1090 (data not shown). Thus, antibody 1090-
10.1 was bound to a determinant exposed at the
cell surface, which was probably a component of
the outer membrane. Antibody from clone 1090-
10.1 was of the IgG2a sublcass, as determined by
immunoelectrophoresis.
Reaction with gonococcal colonial var-
iants. Monoclonal anti-FA1090 antibodies were
tested for their ability to bind to different colony
variants of strain FA1090 by RIA. No significant
differences were observed for antibody binding
to piliated and nonpiliated colony types of strain
FA1090, suggesting that the antibodies were not
directed against pili.
There were differences in the binding of anti-
bodies to different isogenic opacity variants of
strain FA1090. Fifteen variants of strain FA1090
were selected on GCB agar. These variants fell
into three different classes on the basis ofopacity
or transparency of the colonies: six were deeply
opaque, four were transparent, and five were of
intermediate opacity. All variants were nonpi-
liated. Table 1 shows the results of tests of
antibody binding to each ofthese variants. Eight
of the 15 variants exhibited the ability to express
the strain-specific antigen reactive with these
monoclonal antibodies; seven of the variants did
not bind antibody. The five variants of inter-
mediate colony opacity and three of the trans-
parent variants bound antibody. The five deeply
opaque variants all failed to bind antibody. One
TABLE 1. Binding of monoclonal antibody 1090-10.1
to 15 isogenic opacity variants derived from the
parent strain FA1090-
Variant opacity/trapr Antibody boundc
1090-1 Op++ 378± 52
1090-2 Op++ 380 ± 63
1090-3 Op+ 18,277 698
1090-4 Tr 21,292 691
1090-5 Op++ 379 ± 127
1090-6 Op+ 19,521 ±807
1090-7 Tr 20,118 ± 807
1090-8 Op++ 477 ± 39
1090-9 Op+ 17,762 + 1,738
1090-10 Op+ 18,379 + 1,688
1090-11 Op++ 310 ± 27
1090-12 Tr 224 ± 57
1090-13 0p+ 18,667 ± 999
1090-14 Tr 18,523 ± 916
1090-15 Op++ 302 ± 502
a Binding was measured by the "MI-labeled protein
A binding assay. Results were similar with the other
monoclonal antibodies shown in Fig. 1.
b Op+, Intermediate opaque; Op++, very opaque; Tr,
transparent.
' Numbers represent mean counts per minute above
background + standard deviation of the mean deter-
mined from three different wells.
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of the transparent variants (1090-12) also failed
to bind antibody.
Preparation of crude outer membranes of six
of the opacity variants were analyzed by SDS-
PAGE, using the buffer system of Laemmli (12).
Protein profiles of positive and negative anti-
body binding variants were similar (Fig. 4). How-
ever, a protein band (arrow) was apparent in
three variants that bound antibody (variants 6,
7, and 10), whereas this band was not present in
the profiles from variants that did not bind
antibody (variants 5, 8, and 12). Although var-
iants 7 and 12 were indistinguishable in colony
opacity phenotype, since both formed transpar-
ent colonies, there was a difference between
them in the presence of this band on the gel, as
well as in ability to bind antibody.
In other experiments, three transparent colo-
nies were selected from strain FA1090 and
cloned daily for 5 days. Spontaneous opaque
variants were then selected from the transparent
parent clones, and these pairs of variants were
tested for binding of antibody 1090-10.1. In two
of the three pairs of variants, antibody did not
bind to the opaque variants derived from posi-













FIG. 4. SDS-PAGE analysis of outer membranes
from gonococcal opacity variants exhibiting differ-
ences in expression ofFAI090 strain-specific antigen.
The gel was 15% acrylamide-0.4% bisacrylamide, us-
ing the buffers ofLaemmli (12).
DISCUSSION
In this paper, we report the production of
several clones of hybridomas secreting specific
antibodies directed against N. gonorrhoeae
strain FA1090. Hybridomas were produced by
fusion of spleen cells from mice immunized with
whole FA1090 gonococci with a non-immuno-
globulin-secreting mouse myeloma cell line,
Sp2/0 (22).
Antibodies from eight clonally related cell
lines were analyzed for cross-reactivity with het-
erologous strains of gonococci and other Neis-
seria species. Antibodies bound to the homolo-
gous immunizing strain, FA1090; however, there
was little or no binding with 16 other gonococcal
strains tested. There was also little or no binding
to the other Neisseria species tested. Antibodies
from the eight clones exhibited the same binding
patterns with all bacteria tested. The antibodies
were probably directed against a determinant
present on the outer membrane, as evidenced by
their reactivity with both whole cells and puri-
fied outer membranes. This determinant is prob-
ably not pili or LPS, and may be a protein of the
outer membrane. Because these antibodies were
produced by cell lines cloned from a single cul-
ture, it seems likely that they are directed
against the same surface determinant. Further
studies are in progress to determine the exact
nature of the antigen(s) involved in the serolog-
ical reaction.
Piliated and nonpiliated variants of strain
FA1090 showed no significant differences in
binding of the monoclonal antibodies. We also
examined binding of antibodies to different
opacity variants of strain FA1090, since opacity
variants have been shown to differ in outer
membrane protein composition (13, 25). Not all
of the variants tested expressed the specific an-
tigen required for antibody binding. Colony var-
iants oftransparent or intermediate opaque phe-
notype were bound by antibody, with a single
exception (variant 1090-12). Lack of the specific
antigen was correlated with a deeply opaque
colony type. When outer membrane proteins of
six variants were compared by SDS-PAGE,
there was a protein band present in the gels from
three variants that expressed the specific antigen
that was not apparent in three variants lacking
the antigen. The results with variants FA1090-7
and FA1090-12 demonstrated that there were
differences in surface composition that were not
reflected in differences in colony morphology.
These two transparent colony-type variants
were indistinguishable in colony morphology,
but differed both in antibody binding and in
possession of the relevant band on the gels.
Lambden and Heckels (13) have shown that
different opacity variants of a single gonococcal
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strain possess different colony opacity-associ-
ated proteins. These results, and our own, show
that ignificant differences in surface architec-
ture can exist between gonococcal colonies that
are morphologically similar. The classification
of gonococcal colonies according to colony opac-
ity is probably not as sensitive a method for
identifying variants with different surface anti-
gens as is their ability to bind the monoclonal
antibody.
The correlation of antibody binding with the
presence of a specific protein(s) in the cell en-
velope does not necessarily mean that the anti-
body is directed against the protein. An equally
likely possibility is that the exposure of the
actual target antigen is affected by the presence
or absence of the variable protein. In either case,
there must be a mechanism for regulating vari-
ation in expression of antigens. One possible
mechanism would be analogous to phase varia-
tion of the flagellar antigens of Salmonella (28).
Whether the variation of the strain-specific an-
tigen in the gonococcus is regulated by a similar
mechanism is unknown, but deserves further
investigation.
The ability of the gonococcus to exhibit anti-
genic variation may have implications for the
pathogenesis of gonococcal infection. Reinfec-
tion of individuals by the gonococcus can prob-
ably be explained by the antigenic diversity
among different strains of gonococci (8, 27) and
by the inability of the host immune responses to
recognize different gonococcal types. However,
antigenic variation during a single episode of
infection may be partly responsible for the inef-
ficient clearing mechanisms of the infected host
(19). James and Swanson (7) showed that the
opacity/transparency properties, and the pres-
ence of opacity-associated outer membrane pro-
teins, can vary at different times during an in-
fection. They suggested that selection ofvariants
by immunoglobulins, proteolytic enzymes, or
other inhibitory substances was occurring. We
have presented evidence that isogenic variants
of strain FA1090 differ in their ability to express
a surface antigen(s) that specifically reacts with
monoclonal antibodies. Whether this antigen is
important to the virulence of the gonococcus is
not known at this time. Further studies are
needed to determine if variation in the strain-
specific antigen is associated with differences in
biological properties of the organism.
In conclusion, we have described the produc-
tion of monoclonal antibodies directed against
an apparent strain-specific cell surface antigen
of N. gonorrhoeae. These antibodies have pro-
vided sensitive immunological probes for study-
ing the surface properties of the organism. They
should be useful for future investigations on the
immunobiology of the gonococcus and on the
mechanisms involved in variation of gonococcal
surface antigens.
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